Aakaar Medical Technologies share price
NSE: AAKAARPersonal Products
Last close ₹63.80down ₹3.35 (4.99%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹67.15.
52-week range of traded prices to 23 Oct 2026
₹46.00Low, 27 Mar 2026₹90.00High, 24 Oct 2025
- Next results date: the board meets on 30 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹90 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 17 Jun 2026
- 13.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 17 Jun 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 17 Jun 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 17 Jun 2026
- 0.34
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,200100.0% delivered
Results
Standalone; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 17 Jun
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹42 Crup 64.42%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹7.42 CrHalf year to Sep 2025: −₹0.78 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 17.8%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2025Filed 10 Nov | Mar 2026Filed 17 Jun |
|---|---|---|
| Revenue | 25.3 | 41.6 |
| Net profit | −0.8 | 7.4 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −3.1% | 17.8% |
Standalone. The 2 half years from Sep 2025, the first on record. The latest is shaded.
Business segments
Share of revenue, year to Mar 2026, standalone.Segment revenue and profit
- Aesthetic ProductsAesthetic Products, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹59.6 Cr89.0%
- Aesthetic Devices & Device ConsumablesAesthetic Devices & Device Consumables, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹7.4 Cr11.0%
Valuation
Today, against the company's own history. Not shown, EV/EBITDA: a period of the last twelve months does not state its operating profit. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 31% of 207 trading days since Nov 2025.
LowestHighest
Its median1.8Industry median5.6
Peers and competitors
Personal Care, 21 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Aakaar Medical Technologies in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Radix Industries (India)RADIXIND | 207 | 70.7 | 8.9 | 54.3 | −7.0% | +7.6% | 13.3% | 13.9% | 0.00% |
 Macobs TechnologiesMACOBSTECH | 188 | 64.8 | 4.5 | – | – | – | 8.3% | – | 0.00% |
 H. R. Hygiene ProductsHRHYGIENE | 138 | – | – | – | – | – | – | – | 0.00% |
 Thrive Future HabitatsTHRIVE | 96 | – | 1.8 | – | −29.8% | – | −5.3% | −6.8% | 0.00% |
 JHS Svendgaard LaboratoriesJHS | 74 | – | 0.4 | 22.9 | +19.4% | – | −1.1% | −2.3% | 0.00% |
 RavelcareRAVEL | 63 | 12.3 | 1.7 | – | – | – | 13.8% | – | 0.00% |
 Medistep HealthcareMEDISTEP | 30 | 5.1 | 0.8 | 4.2 | – | – | 15.8% | – | 0.00% |
 Novateor Research LaboratoriesNOVATEOR | 23 | 211.6 | 2.0 | – | +37.8% | +32.9% | 1.0% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
17 Oct · Analysts
Sep 2026
16 Sep · Analysts
8 Sep · Analysts
Aug 2026
31 Aug · Analysts
25 Aug · Analysts
Aakaar Medical Technologies share price by year
Each calendar year to 2025.Aakaar Medical Technologies share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 73.75 | – | 101.35 | 63.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 27 Jun 2025.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 64.05 | 64.05 | 63.80 | 63.80 | 63.92 | 3,200 | 100.0% |
| 22 Oct 2026 | 67.05 | 67.15 | 67.05 | 67.15 | 67.08 | 6,400 | 100.0% |
| 21 Oct 2026 | 65.00 | 65.00 | 65.00 | 65.00 | 65.00 | 1,600 | 100.0% |
| 19 Oct 2026 | 71.00 | 71.00 | 67.45 | 67.45 | 70.58 | 27,200 | 100.0% |
| 16 Oct 2026 | 71.00 | 71.00 | 71.00 | 71.00 | 71.00 | 14,400 | 100.0% |
| 14 Oct 2026 | 69.30 | 71.00 | 69.30 | 70.95 | 70.74 | 12,800 | 87.5% |
| 13 Oct 2026 | 70.00 | 70.00 | 69.25 | 69.25 | 69.88 | 9,600 | 100.0% |
| 12 Oct 2026 | 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | 1,600 | 100.0% |
| 9 Oct 2026 | 68.00 | 68.00 | 68.00 | 68.00 | 68.00 | 1,600 | 100.0% |
| 7 Oct 2026 | 66.00 | 66.00 | 66.00 | 66.00 | 66.00 | 1,600 | 100.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Aakaar Medical Technologies Limited
- NSE symbol
- AAKAAR
- ISIN
- INE1GYP01013
- Industry
- Personal Products
- Listed
- Jun 2025
- Face value
- ₹10